Medical News

RSS

Washington State Department of Health shows smoking inside homes drops by 61% since 2000

New research released today by the Washington State Department of Health shows the number of people smoking inside homes in our state has declined by 61 percent since 2000. The drop is more than double the overall decline in adult smoking during the same period.

21 May 2010

Study explores genetic imbalances that give rise to childhood brain tumors

The most comprehensive analysis yet of the genetic imbalances at the heart of childhood brain tumors known as high-grade gliomas (HGGs) identified a cancer gene that is unusually active in some tumors and is now the focus of a St. Jude Children's Research Hospital clinical trial.

21 May 2010

PTCL trial data on belinostat to be presented at 2010 ASCO Annual Meeting

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in hematology and oncology, today announced that clinical data on belinostat will be presented at the 2010 Annual Meeting of the American Society of Clinical Oncology, to be held June 4-8, 2010 at the McCormick Place Convention Center in Chicago, Illinois, as part of the ASCO proceedings.

21 May 2010

STAAR Surgical to retire 1.7 million preferred shares through cash payment to Canon companies of $6.8M

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that it will retire 1.7 million preferred shares through a cash payment to the Canon companies of $6.8 million. STAAR originally issued the 1.7 million Series A Convertible Preferred shares as part of the Company's December 2007 purchase of the remaining 50% interest in Canon Staar Co., Inc.

21 May 2010

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Oncolytics Biotech Inc. announced today that abstracts covering clinical research with reovirus (REOLYSIN(R)) are available on the American Society of Clinical Oncology website at www.asco.org, and on the Oncolytics website at www.oncolyticsbiotech.com.

21 May 2010

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

21 May 2010

New therapy program serves as foundation for ongoing clinical development

The researchers of the University of Helsinki, and Oncos Therapeutics, the biotech company developing new cancer therapeutics based on the next generation oncolytic viruses, published initial results from their Advanced Therapy Access Program in Cancer Research.

21 May 2010

First Edition: May 21, 2010

In today's headlines, legislation containing a Medicare pay 'fix' and an extension of the COBRA subsidy is moving toward House consideration.

21 May 2010

Cancer Institute of New Jersey investigators target autophagy

In an effort to improve current anticancer treatments, investigators at The Cancer Institute of New Jersey (CINJ) have been targeting a process known as autophagy, in which cancer cells eat themselves as a measure of self preservation under chemotherapy and radiation stress, thus prolonging tumor cell survival and inducing resistance to therapy.

21 May 2010

Common misconceptions about general anesthesia

Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.

21 May 2010

Blood biomarker underscores role of inflammation in vascular disease

UC Davis researchers have discovered that a blood component linked with inflammation can predict coronary artery disease in African-Americans.

21 May 2010

New drug testing technique is safe and effective

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time.

21 May 2010

Smoking cessation treatments effective and safe for people with schizophrenia

In a study published today in the journal Addiction, researchers have determined that treatment for smoking dependence is as effective among people with severe mental illnesses as it is for the general population. Importantly, they also found that offering such treatments does not appear to cause deterioration in mental health.

21 May 2010

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.

21 May 2010

SAMHSA study reveals differences in rates of substance use among various Asian-American adults

A new national study by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows there are significant differences in rates of substance use among adults in various Asian-American populations. For example, the past month binge drinking rate among Korean-American adults is three times higher than among Chinese-American adults (25.9 percent versus 8.4 percent). Similarly the level of past month illicit drug use among Japanese-American adults is nearly three times higher than the level among Asian Indian-American adults.

21 May 2010

NCCA to host innovative lifelong learning arts programs in San Francisco

Ever wondered why creativity and learning are so important for the older brain? National Center for Creative Aging (NCCA) will answer this question and highlight innovative lifelong learning arts programs at the "NCCA-MetLife Foundation Creativity Matters: Lifelong Learning Through the Arts" symposium.

21 May 2010

Rush University College of Nursing professor receives Flame of Excellence Award from AACN

The American Association of Critical-Care Nurses will give the Flame of Excellence Award to Ruth Kleinpell at the 2010 National Teaching Institute & Critical Care Exposition, Washington, D.C., May 15-20.

21 May 2010

Pluristem to highlight potential of PLX-PAD cell therapy for critical limb ischemia at 16th ISCT

Pluristem Therapeutics Inc. today announced that its off-the-shelf placenta-derived cell therapies will be the focus of presentations at upcoming investor and medical conferences.

21 May 2010

Study investigates firearm fatalities among under age youths

Over three-quarters of youths under age 15 who die in firearm accidents are shot by another person, usually another youth, according to new research from the Harvard School of Public Health (HSPH).

21 May 2010

Researchers propose steps to enhance patient-physician communication to improve depression care

Because people with depression often do not recognize they have a problem or are unable to describe their distress, many do not seek treatment. About a quarter of those with major depression are undiagnosed, according to several studies, and fewer than half receive treatment.

21 May 2010

Medical News

Washington State Department of Health shows smoking inside homes drops by 61% since 2000

Study explores genetic imbalances that give rise to childhood brain tumors

PTCL trial data on belinostat to be presented at 2010 ASCO Annual Meeting

STAAR Surgical to retire 1.7 million preferred shares through cash payment to Canon companies of $6.8M

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

New therapy program serves as foundation for ongoing clinical development

First Edition: May 21, 2010

Cancer Institute of New Jersey investigators target autophagy

Common misconceptions about general anesthesia

Blood biomarker underscores role of inflammation in vascular disease

New drug testing technique is safe and effective

Smoking cessation treatments effective and safe for people with schizophrenia

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

SAMHSA study reveals differences in rates of substance use among various Asian-American adults

NCCA to host innovative lifelong learning arts programs in San Francisco

Rush University College of Nursing professor receives Flame of Excellence Award from AACN

Pluristem to highlight potential of PLX-PAD cell therapy for critical limb ischemia at 16th ISCT

Study investigates firearm fatalities among under age youths

Researchers propose steps to enhance patient-physician communication to improve depression care

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News